Literature DB >> 8948637

Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome.

A Elia1, K G Laing, A Schofield, V J Tilleray, M J Clemens.   

Abstract

During the initial infection of B lymphocytes by Epstein-Barr virus (EBV) only a few viral genes are expressed, six of which encode the EBV nuclear antigens, EBNAs 1-6. The majority of EBNA mRNAs share common 5'-ends containing a variable number of two alternating and repeated exons transcribed from the BamHI W major internal repeats of the viral DNA. These sequences can also exist as independent small RNA species in some EBV-infected cell types. We present evidence that transcripts from these W repeat regions can exert a trans-acting effect on protein synthesis, through their ability to activate the dsRNA-dependent protein kinase PKR. UV cross-linking and filter binding assays have demonstrated that the W transcripts bind specifically to PKR and can compete with another EBV-encoded small RNA, EBER-1, which was shown previously to bind this kinase. In the reticulocyte lysate system the W RNAs shut off protein synthesis through an ability to activate PKR. In contrast to EBER-1, the W RNAs are unable to block the dsRNA-dependent activation of PKR. Using a purified preparation of the protein kinase we have shown that the W transcripts directly activate PKR in vitro. The results suggest that EBV has the ability both to activate and to inhibit PKR through the actions of different products of viral transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948637      PMCID: PMC146269          DOI: 10.1093/nar/24.22.4471

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  52 in total

1.  Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector.

Authors:  K H Mellits; T Pe'ery; L Manche; H D Robertson; M B Mathews
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

2.  Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI.

Authors:  P A Clarke; M Schwemmle; J Schickinger; K Hilse; M J Clemens
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

3.  Translational control by the Epstein-Barr virus small RNA EBER-1. Reversal of the double-stranded RNA-induced inhibition of protein synthesis in reticulocyte lysates.

Authors:  P A Clarke; N A Sharp; M J Clemens
Journal:  Eur J Biochem       Date:  1990-11-13

4.  Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state.

Authors:  P A Clarke; N A Sharp; J R Arrand; M J Clemens
Journal:  Biochim Biophys Acta       Date:  1990-08-27

5.  Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs.

Authors:  M Kozak
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase.

Authors:  S Gunnery; A P Rice; H D Robertson; M B Mathews
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.

Authors:  M Woisetschlaeger; C N Yandava; L A Furmanski; J L Strominger; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase.

Authors:  S Roy; M Agy; A G Hovanessian; N Sonenberg; M G Katze
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Early events in Epstein-Barr virus infection of human B lymphocytes.

Authors:  C Alfieri; M Birkenbach; E Kieff
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

10.  Alternative splicing dictates translational start in Epstein-Barr virus transcripts.

Authors:  R P Rogers; M Woisetschlaeger; S H Speck
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  12 in total

1.  Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.

Authors:  Y Gao; S a Xue; B E Griffin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

3.  Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation.

Authors:  Jeremy Poppers; Matthew Mulvey; Cesar Perez; David Khoo; Ian Mohr
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 4.  Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes.

Authors:  M Kumar; G G Carmichael
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

5.  Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22.

Authors:  Victor Fok; Rachel M Mitton-Fry; Angie Grech; Joan A Steitz
Journal:  RNA       Date:  2006-03-23       Impact factor: 4.942

Review 6.  Epstein-Barr virus and Burkitt lymphoma.

Authors:  G Brady; G J MacArthur; P J Farrell
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

7.  Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma.

Authors:  Antonella Farina; Mara Cirone; Michael York; Stefania Lenna; Cristina Padilla; Sarah Mclaughlin; Alberto Faggioni; Robert Lafyatis; Maria Trojanowska; Giuseppina A Farina
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

8.  The innate antiviral immune system of the cat: molecular tools for the measurement of its state of activation.

Authors:  Céline Robert-Tissot; Vera L Rüegger; Valentino Cattori; Marina L Meli; Barbara Riond; Maria Alice Gomes-Keller; Andrea Vögtlin; Burghardt Wittig; Christiane Juhls; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

Review 9.  The interferon response circuit: induction and suppression by pathogenic viruses.

Authors:  Otto Haller; Georg Kochs; Friedemann Weber
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

Review 10.  Interferon, Mx, and viral countermeasures.

Authors:  Otto Haller; Georg Kochs; Friedemann Weber
Journal:  Cytokine Growth Factor Rev       Date:  2007-08-01       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.